Veronica Acosta joined Denver7 in January 2021 as a reporter.
WATKINS, Colo. — The federal government's decision to reclassify marijuana from a Schedule 1 drug, like heroin, to a Schedule 3 drug, like Tylenol with Codeine, is paving the way for medical cannabis businesses to expand.
READ MORE: CO cannabis industry anticipates potential federal reclassification under TrumpPriyanka Sharma is the co-founder and co-CEO of Kazmira Therapeutics, a company with a warehouse in Watkins that prepares and dispenses CBD to patients. The reclassification of marijuana means she and her partner can expand the business, going from just providing CBD to soon providing THC for patients, as well.
'I think that this plant is just it's not well understood yet,' Sharma said. 'That's such a big shift, because it allows now patients and doctors to start having conversations about what medical marijuana is doing for these patients to actually solve symptoms of real medical conditions,' Sharma told Denver7's Veronica Acosta. Brian Vicente, founding partner of Vicente LLP, spent years working to get marijuana reclassified.
'They no longer have this Reefer Madness mentality,' Vicente said. 'Medical specific businesses were really called out in this federal order,' he added. 'They said, You know, if you are operating under a state license as a medical operator, you know, we are putting you on this sort of path towards legitimization,' Vicente said. For those like Sharma who help people medically with the plant, there is now more to explore legally.
'It hasn't been able to be handled by pharmaceutical company. It hasn't been able to be handled by researchers,' Sharma said.
Kazmira Therapeutics Schedule 3 Drug THC Cbd Federal Marijuana Laws Marijuana Reclassification Medical Cannabis
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Colorado fire crews, Xcel Energy on alert amid high fire dangerVeronica Acosta joined Denver7 in January 2021 as a reporter.
Read more »
Why Trump Could Be About To Loosen Restrictions on MarijuanaThe Trump administration is considering a possible move to reclassify marijuana from Schedule I to III.
Read more »
Todd Blanche orders federal reclassification of medical marijuana as less dangerousTodd Blanche signed an order reclassifying state-licensed medical marijuana from a Schedule I to a less-regulated Schedule III drug.
Read more »
Trump reclassifies state-licensed medical marijuana as a less-dangerous drug in a historic shiftMarijuana or marijuana-derived products that are not distributed through a state medical marijuana program will continue to be classified in Schedule I.
Read more »
Trump administration officially reclassifies state-licensed medical marijuana as Schedule IIIThe Trump administration said this move, which does not legalize marijuana for medical or recreational use under federal law, is just the start of a process to reclassify the drug more broadly
Read more »
Trump Administration Reschedules Medical Marijuana, Offers Tax ReliefThe Trump administration has reclassified medical marijuana to a less restrictive category and granted tax benefits to licensed operators, marking a significant policy shift. This change moves medical marijuana from Schedule I to Schedule III, easing research barriers and allowing state-licensed businesses to deduct federal taxes. However, it does not legalize marijuana nationally.
Read more »